Glecaprevir/pibrentasvir Treats Hepatitis C in HIV-coinfected Individuals Glecaprevir/pibrentasvir Treats Hepatitis C in HIV-coinfected Individuals

The direct-acting antiviral (DAA) combination glecaprevir/pibrentasvir is effective for treating hepatitis C virus (HCV) infection in individuals coinfected with HIV-1, according to results from the non-randomized, open-label phase 3 EXPEDITION-2 trial.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news